Sodium Alginate Nanoparticles of Isonizid: Preparation and Evaluation
Abstract
Fabrication and evaluation of the Isoniazid loaded sodium alginate nanoparticles (NPs) was main objective of current investigation. These NPs were engineered using ionotropic gelation technique. The NPs fabricated, were evaluated for average particle size, encapsulation efficiency, drug loading, and FTIR spectroscopy along with in vitro drug release. The particle size, drug loading and encapsulation efficiency of fabricated nanoparticles were ranging from 230.7 to 532.1 nm, 5.88% to 11.37% and 30.29% to 59.70% respectively. Amongst all batches studied formulation F-8 showed the best sustained release of drug at the end of 24 hours.
Keywords:
Isoniazid, sodium alginate nanoparticles, in vitro release.DOI
https://doi.org/10.25004/IJPSDR.2019.110616References
Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005; 293(22):2767-2775.
Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111:1168–1173.
Pandey R, Khuller GK. Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother 2005; 55: 430–435.
Ain Q, Sharma S, Khuller GK, Garg SK. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. J Antimicrob Chemother 2003; 51:931–938.
Labana S, Pandey R, Sharma S, Khuller GK. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Int J Antimicrob Agents 2002; 20:301-304.
Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21: 387-422.
Tonnesen HH, Karlsn J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002; 28:621–630.
Pandey R, Khuller GK. Chemotherapeutic potential of alginate–chitosan microspheres as antitubercular drug carriers. J Antimicrob Chemother 2004; 53:635-640.
Jain D, Bar-Shalom D. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research. Drug Dev Ind Pharm. 2014; 40:1576–1584.
Zhan XP, Wu GH. Characteristics of sodium alginate and its application in food. Food Eng 2011; 1:7–9.
Ahmad Z, Pandey R, Sharma S, Khuller GK. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses. Int J Antimicrob Agents 2006; 27(5):409-416.
Dornish M, Hagen A, Hansson E, Peucheur C, Vedier F, Skaugrud O. Safety of ProtasanTM: ultrapure chitosan salts for biomedical and pharmaceutical use, in: A. Domard, G.A.F. Roberts, K.M. Varum (Eds.), Advances in Chitin Science, Jacques Andre Publisher, Lyon, 1997: 664–670.
Chen Y, Ye Q, Gong T, Kuang J, Li S. Preparation of Doxorubicin-loading Sodium Alginate Nanoparticles and its Anticancer Activity in HepG2 cells. J Pharm Biomed Sci 2019; 8(5):79-83.
Sailaja AK, Amareshwar P, Chakravarty P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int J Pharm Pharm Sci. 2011; 3(2):45-50.
Rajaram S, Natham R. Influence of Formulation and Process Variables on the Formation of Rifampicin Nanoparticles by Ionic Gelation Technique. RJPBCS 2013; 4: 820-832.
Gaikwad A, Tamizhrasi S, Sorti A, Gavali P, Mehare G. Formulation and in vitro characterization of polymethacrylic acid nanoparticle containing frusemide. Int J Pharmtech Res 2010; 2: 300-304.
Bathool A, Vishakante GD, Khan MS, Shivakumar HG. Development and Characterization of Atorvastatin Calcium Loaded Chitosan Nanoparticles For Sustain Drug Delivery. Adv Mat Lett 2012; 3 (6): 466-470
Nagajyothi B, Babu MK. Design & development of glipizide fast dissolving tablets using natural gum superdisintegrant. AJPCR 2014; 7:144-148.
Published
Abstract Display: 531 
PDF Downloads: 768 
